Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Biotechnology
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (OTCID:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(1)
•••
Pronorvista
X
Comment by
Pronorvista
on Feb 23, 2024 4:19pm
RE:Lots of dillution😮
no chance that the warrants will be exercised at this price
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 23, 2024 2:03pm
Lots of dillution😮
to come above the $1 level, could be some warrants being exercised today.
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 23, 2024 12:12pm
Played like a fiddle🎻
lol
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 23, 2024 11:16am
RE:RE:Where is that nuance arbitration
what prediction's are you talking about? i sold some yesterday but why would i dump now when i just loaded up this morning on the pullback @95 cents. lol
(5)
•••
Mmmtroll
X
Comment by
Mmmtroll
on Feb 23, 2024 10:41am
RE:Where is that nuance arbitration
Man dumpster your predictions are worse than the weatherman guessing your local forecast. Sell your shares you gotta be up like what a week of lunch money?
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 22, 2024 10:44am
Where is that nuance arbitration
decision news, i thought for sure it would be out this week. let us hope it is not an end of day friday news dump.
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 18, 2024 10:46am
RE:RE:Pivotal Trial Post...
Now ... bypassing P2 chronic is something else I'm investigating and I think that's possible.
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 17, 2024 6:08pm
RE:Pivotal Trial Post...
Page 28 of the presentation shows the potential to bypass P3 soft tissue. This doesn't mean that a full P3 can be bypassed - just the soft tissue portion. We would still need to do a
...more
(55)
•••
Harper75
X
Post by
Harper75
on Feb 17, 2024 8:33am
Pivotal Trial Post...
@Mugsy - what do yiu think of this post off another Antibe Discord site? I like the potential of a pivotal trial if accepted we could bypass p3. Normally not done at p2. They also added placebo and
...more
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 16, 2024 1:02pm
Ate is on the move
march should be a very good month for shareholders
(128)
•••
MrMugsy
X
Post by
MrMugsy
on Feb 16, 2024 9:00am
Settled.
Oh ... it's settled. Arbitration with Nuance Pharma: the parties have been advised that the decision has been filed and will be released following the completion of remaining administrative
...more
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 15, 2024 9:21am
Maybe antibe wins the case
Further to the disclosure provided in the Company’s most recent Annual Information Form (“AIF”), the dispute with Nuance Pharma has not yet been settled.1 Accordingly, the parties will be
...more
(1566)
•••
Duster340
X
Post by
Duster340
on Feb 15, 2024 9:10am
Singapore International Arbitration Centre.
#8 no minimum or maximum claim amount, but does not mention min or max reward. there may not be one? 8 Is there a minimum or maximum claim amount for SIAC arbitrations? No. There is no minimum or
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 14, 2024 9:44pm
RE:RE:Lots of cash
The burn rate is the burn rate - for this company it could fluctuate incredibly. All the while, they're already looking at options. I am assuming that we can get as low as $6-$8 MM in the
...more
(128)
•••
MrMugsy
X
Comment by
MrMugsy
on Feb 14, 2024 9:31pm
RE:RE:RE:RE:Lots of cash
Highly doubt there is a million dollar limit in a pharma case.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Podcasts